Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFLX.L Regulatory News (FLX)

  • There is currently no data for FLX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of Chief Finance Officer

8 Mar 2017 07:00

RNS Number : 8044Y
Falanx Group Limited
08 March 2017
 

Falanx Group Limited

("Falanx" or "the Company")

 

APPOINTMENT OF CHIEF FINANCE OFFICER

 

Falanx Group (AIM:FLX), the global intelligence, security and cyber defence provider, is pleased to announce the appointment of Craig Dawson as Chief Finance Officer with immediate effect.

 

Craig joins Falanx for an initial period of 6 months and will, ex-officio, attend board meetings and structure the financial organisation and planning of Falanx Group. Craig is not joining the Board of the Company.

 

Prior to Falanx, Craig served as Finance Director and Executive Committee member at Global Strategies Group (London) ("Global"). Global Strategies Group is a worldwide defence organisation offering technology, consultancy and services to meet National Security, Critical Infrastructure Protection and Enterprise Risk Management needs. Global at one stage generated annual turnover in excess of $500m, with operations stretching over 5 continents and consisting of approximately 5,000 employees and contractors.

 

Craig had direct oversight of the Group Finance function in London and also oversaw the international subsidiary finance functions. In the 6 years at Global, Craig played a key role in:

 

· An equity raise of $73m on the NASDAQ and the acquisition of STG Inc, a Cyber Security, Software Development, Intelligence and Analytics company servicing the US Government, for $165.5m.

· Trebling revenue and EBITDA of the Security Services arm of Global between 2010 and 2013 at a CAGR of 41%.

· Financial reporting, structure and taxation planning of the $120m IPO of Global Defence Technology & Systems, Inc. ("GTEC") on the NASDAQ in 2009. At the time of IPO, GTEC enjoyed more than $200m in revenue and $15m of EBITDA. After making two acquisitions in 2010, it was sold at a 50% premium above its share price to Ares Management (a PE enterprise) in April 2011.

 

Prior to joining Global, Craig performed audit and advisory assurance services at Deloitte LLP for a broad range of clients, including FTSE listed institutions in the Technology, Media and Telecommunications (TMT) sector. Craig acted for companies such as: Anite Plc, producer of wireless test systems; Bell Microproducts, a technology wholesaler; BancTec, a global leader in providing financial transaction automation and document management; and Damovo, a provider of technology enabled solutions to enterprises.

 

Mike Read, Chairman of Falanx Group, commented:

 

"We are delighted that Craig has chosen to bring his immense experience in the Defence and Technology sector to Falanx and assist us in building a market leading UK Cyber success story, as he has done so many times in the past."

 

Enquiries:

 

Falanx Group Limited

Stuart Bladen, Chief Executive Officer

 

 

www.falanxgroup.com

www.falanxassuria.com

www.falanxcyberdefence.com

SPARK Advisory Partners Limited

Nominated Adviser

Matt Davis / James Keeshan

 

+44 (0) 203 368 3551

 

Whitman Howard Limited

Broker

Nick Lovering / Francis North

 

+44 (0) 207 659 1234

About Falanx

Falanx Group Limited, is a global intelligence and cyber defence provider working with blue chip and government clients. The Group listed on AIM in June 2013 under ticker FLX For more information: http://www.falanxgroup.com/

 

MAR

This announcement contains inside information for purposes of Article 7 of Regulation (EU) No 596/2014

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCDDGDXLBGBGRR
Date   Source Headline
9th Dec 20222:42 pmRNSHolding(s) in Company
8th Dec 20224:29 pmRNSResult of AGM
8th Dec 20227:00 amRNSInterim Results
24th Nov 20225:17 pmRNSHolding(s) in Company
15th Nov 20225:56 pmRNSNotice of AGM
18th Oct 20227:00 amRNSDirectorate Change
29th Sep 20227:00 amRNSFinal Results
20th Sep 20227:00 amRNSHolding(s) in Company
5th Sep 20224:53 pmRNSHolding(s) in Company
4th Aug 20222:06 pmRNSSecond Price Monitoring Extn
4th Aug 20222:00 pmRNSPrice Monitoring Extension
4th Aug 202211:05 amRNSSecond Price Monitoring Extn
4th Aug 202211:00 amRNSPrice Monitoring Extension
4th Aug 20227:00 amRNSTrading Update
9th May 20227:00 amRNSPartnership to Provide M-EDR to UK Customers
8th Apr 20224:06 pmRNSHolding(s) in Company
6th Apr 202211:59 amRNSHolding(s) in Company
1st Apr 20227:00 amRNSChange of Adviser
30th Mar 20222:44 pmRNSDirector/PDMR Shareholding
23rd Mar 202212:59 pmRNSDirector/PDMR Shareholding
10th Feb 202211:11 amRNSDirector/PDMR Shareholding
24th Jan 20227:00 amRNSDirector/PDMR Shareholding
19th Jan 20225:20 pmRNSHolding(s) in Company
19th Jan 20227:00 amRNSDirector/PDMR Shareholding
7th Dec 202111:14 amRNSResult of AGM
7th Dec 20217:00 amRNSInterim Results
16th Nov 20212:10 pmRNSNotice of AGM
29th Oct 20211:57 pmRNSExercise of Options, TVR and PDMR dealing
27th Oct 20219:03 amRNSDirector/PDMR Shareholding
26th Oct 20217:00 amRNSDirector/PDMR Shareholding
25th Oct 20213:25 pmRNSExercise of Options and TVR
13th Oct 202111:06 amRNSSecond Price Monitoring Extn
13th Oct 202111:00 amRNSPrice Monitoring Extension
13th Oct 20217:00 amRNSTrading update and BOOST&Co loan facility update
6th Oct 20214:41 pmRNSSecond Price Monitoring Extn
6th Oct 20214:35 pmRNSPrice Monitoring Extension
6th Oct 20212:43 pmRNSSale of Assynt for £4.6 million
4th Oct 20217:00 amRNSFalanx Launch Mass Market Security Assessment Tool
29th Sep 20217:00 amRNSAnnual results for the year ended 31 March 2021
18th Aug 20217:01 amRNSGrant of share options
18th Aug 20217:00 amRNSTrading Update & New Loan Facility
9th Jul 20219:07 amRNSHolding(s) in Company
29th Apr 20217:00 amRNSCancellation of unapproved Share Options
1st Apr 20217:00 amRNSIssue of Equity and TVR
26th Feb 20213:31 pmRNSResult of GM
10th Feb 20212:03 pmRNSPublication of Circular & Notice of GM
8th Feb 202111:05 amRNSSecond Price Monitoring Extn
8th Feb 202111:00 amRNSPrice Monitoring Extension
5th Feb 20217:00 amRNSContract Wins and Covid Business Interruption Loan
18th Jan 20212:06 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.